A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)
Clinical trial NCT01433991 · TERMINATED
Trial details
- NCT number
- NCT01433991
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-13
- Primary completion
- 2015-03-18
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.